Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 238,202 | 248,360 | 227,960 | 233,300 | 264,474 |
| Cost of Goods | 43,326 | 48,519 | 46,430 | 46,560 | 49,517 |
| Gross Profit | 194,876 | 199,841 | 181,530 | 186,740 | 214,957 |
| Operating Expenses | 170,802 | 173,515 | 159,409 | 164,670 | 186,108 |
| Operating Income | 24,400 | 26,845 | 22,551 | 22,630 | 29,366 |
| Interest Expense | 43 | 31 | 32 | 32 | 96 |
| Other Income | 2,453 | 1,687 | 283 | 626 | 38 |
| Pre-tax Income | 26,810 | 28,501 | 22,802 | 23,224 | 29,308 |
| Income Tax | 9,518 | 10,118 | 10,007 | 8,295 | 10,151 |
| Net Income Continuous | 17,292 | 18,383 | 12,795 | 14,929 | 19,157 |
| Net Income | $17,292 | $18,383 | $12,795 | $14,929 | $19,157 |
| EPS Basic Total Ops | 0.89 | 0.95 | 0.66 | 0.78 | 1.00 |
| EPS Basic Continuous Ops | 0.90 | 0.95 | 0.67 | 0.78 | 1.00 |
| EPS Diluted Total Ops | 0.89 | 0.95 | 0.66 | 0.78 | 1.00 |
| EPS Diluted Continuous Ops | 0.89 | 0.95 | 0.67 | 0.78 | 1.00 |
| EPS Diluted Before Non-Recurring Items | 0.89 | 0.95 | 0.66 | N/A | N/A |
| EBITDA(a) | $29,541 | $32,069 | $27,803 | $28,055 | $34,493 |